In many modern applications from, for example, bioinformatics and computer vision, samples have multiple feature representations coming from different data sources. Multiview learning algorithms try to exploit all these available information to obtain a better learner in such scenarios. In this paper, we propose a novel multiple kernel learning algorithm that extends kernel k -means clustering to the multiview setting, which combines kernels calculated on the views in a localized way to better capture sample-specific characteristics of the data. We demonstrate the better performance of our localized data fusion approach on a human colon and rectal cancer data set by clustering patients. Our method finds more relevant prognostic patient groups than global data fusion methods when we evaluate the results with respect to three commonly used clinical biomarkers.

First provide a summary of the paper, and then address the following criteria: Quality, clarity, originality and significance. This paper generalizes multi-kernel k-means clustering (solved via relaxation) to the case where each clustered item (here, a person) gets an item-specific set of weights over the multiple kernels, rather than the traditional, shared, global weighting of the kernels. Using TCGA (cancer) data, with 3 modalities, they demonstrate that this generalization yields better clusterings than the traditional (global approach), when measured against 3 bronze standard clusterings arising from known clinical clusters. The writing is clear, making for an easy read. Although this is a somewhat incremental-seeming tweak, I think it was clever, with the potential to actually be used (rather than lost in the NIPS archives), and therefore of some significance. Other comments: In the introduction you mention that k-means is susceptible to local minima, and then use this to motivate the relaxation approach.

Clinical workflows in oncology rely on predictive and prognostic molecular biomarkers. However, the growing number of these complex biomarkers tends to increase the cost and time for decision-making in routine daily oncology practice; furthermore, biomarkers often require tumour tissue on top of routine diagnostic material. Nevertheless, routinely available tumour tissue contains an abundance of clinically relevant information that is currently not fully exploited. Advances in deep learning (DL), an artificial intelligence (AI) technology, have enabled the extraction of previously hidden information directly from routine histology images of cancer, providing potentially clinically useful information. Here, we outline emerging concepts of how DL can extract biomarkers directly from histology images and summarise studies of basic and advanced image analysis for cancer histology. Basic image analysis tasks include detection, grading and subtyping of tumour tissue in histology images; they are aimed at automating pathology workflows and consequently do not immediately translate into clinical decisions. Exceeding such basic approaches, DL has also been used for advanced image analysis tasks, which have the potential of directly affecting clinical decision-making processes. These advanced approaches include inference of molecular features, prediction of survival and end-to-end prediction of therapy response. Predictions made by such DL systems could simplify and enrich clinical decision-making, but require rigorous external validation in clinical settings.

Maintaining good cardiac function for as long as possible is a major concern for healthcare systems worldwide and there is much interest in learning more about the impact of different risk factors on cardiac health. The aim of this study is to analyze the impact of systolic blood pressure (SBP) on cardiac function while preserving the interpretability of the model using known clinical biomarkers in a large cohort of the UK Biobank population. We propose a novel framework that combines deep learning based estimation of interpretable clinical biomarkers from cardiac cine MR data with a variational autoencoder (VAE). The VAE architecture integrates a regression loss in the latent space, which enables the progression of cardiac health with SBP to be learnt. Results on 3,600 subjects from the UK Biobank show that the proposed model allows us to gain important insight into the deterioration of cardiac function with increasing SBP, identify key interpretable factors involved in this process, and lastly exploit the model to understand patterns of positive and adverse adaptation of cardiac function.